Massivemarkets

SEC Form 4

Sight Sciences, Inc. (SGHT) insider trading

In the 12 months to Oct 26, 2026, 6 SGHT insiders reported open-market sales of $2.9M across 32 filings; one director bought $184.8K.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$2.9M
32 filings · 6 insiders
Open-market purchases
$184.8K
2 filings · Staffan Encrantz, Director
Pre-arranged sales (10b5-1)
25 of 32
$2.2M of $2.9M sold (76%)

Who traded SGHT, and when

  • Purchase
  • Sale
  • Sale, pre-arranged (10b5-1)

SGHT daily close from Oct 27, 2025 to Oct 26, 2026, between $3.45 and $9.36, last $9.06. 32 sale and 2 purchase filings by 7 insiders, marked at their filing dates. Paul Badawi, President and CEO: sold $957.2K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. Alison Bauerlein, Chief Operating Officer: sold $665.8K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. Jeremy B. Hayden, Chief Legal Officer: sold $635.1K across 6 filings, first filed Nov 14, 2025, last Jul 6, 2026. David Badawi, Chief Technology Officer: sold $245.0K across 5 filings, first filed Jan 6, 2026, last Oct 5, 2026. James Rodberg, Chief Financial Officer: sold $203.5K across 6 filings, first filed Dec 3, 2025, last Oct 5, 2026. Staffan Encrantz, Director: bought $184.8K across 2 filings, first filed Dec 18, 2025, last Jun 11, 2026. Brenton Taylor, EVP, Operations & R&D: sold $158.8K across 5 filings, first filed Nov 18, 2025, last Oct 5, 2026.

Largest mark · tap a row for others

Jeremy B. Hayden · Chief Legal Officer

Sale $362,388

44,850 shares at $8.08 avg

Filed Nov 26, 2025 · traded Nov 25

Pre-arranged (10b5-1) · close on filing date $8.39

SGHT daily closelast $9.06

Paul Badawi · President and CEO

$957.2K sold

Alison Bauerlein · Chief Operating Officer

$665.8K sold

Jeremy B. Hayden · Chief Legal Officer

$635.1K sold

David Badawi · Chief Technology Officer

$245.0K sold

James Rodberg · Chief Financial Officer

$203.5K sold

Staffan Encrantz · Director

$184.8K bought

Brenton Taylor · EVP, Operations & R&D

$158.8K sold
One row per insider; marks sit at the SEC filing date, sized by dollar value.

Open-market trades

34 filings in the last 12 months
Other insider activity (not market trades) · 20 records
  • Option exercises6 records
  • Grants and awards14 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Pre-arranged (10b5-1)
The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.

Frequently asked questions

Has Sight Sciences, Inc.'s CEO sold stock?

Yes. Paul Badawi (CEO) sold 147,169 shares ($957.2K) between Jan 2026 and Oct 2026, $680.0K of it under a pre-arranged 10b5-1 plan.

How current is SGHT’s insider data?

These are SGHT Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

Build with AI

Track SGHT insider trades with your agent

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for SGHT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.